Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.

about

Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities.

P2860

Q48295024-0BBF424F-D168-4017-8E35-4D2F1D71BE18

P2860

Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.

Item

http://www.wikidata.org/entity/Q48229580

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Role of anthracycline and comp ...... diffuse large B-cell lymphoma.

@en

Role of anthracycline and comp ...... diffuse large B-cell lymphoma.

@nl

type

Item

label

Role of anthracycline and comp ...... diffuse large B-cell lymphoma.

@en

Role of anthracycline and comp ...... diffuse large B-cell lymphoma.

@nl

prefLabel

Role of anthracycline and comp ...... diffuse large B-cell lymphoma.

@en

Role of anthracycline and comp ...... diffuse large B-cell lymphoma.

@nl

P1476

Role of anthracycline and comp ...... diffuse large B-cell lymphoma

@en

P2093

Christopher R Flowers

http://www.w3.org/2001/XMLSchema#string

Madhusmita Behera

http://www.w3.org/2001/XMLSchema#string

P2860

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.

Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.

Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis.

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.

P304

2180-2185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2017-05-736975

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Richard J Lin

Catherine S.M. Diefenbach

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28814386

http://www.w3.org/2001/XMLSchema#string

P932

5691244

http://www.w3.org/2001/XMLSchema#string

Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.

about

P2860

P2860

Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932